5 Things Green Organic Dutchman (TSX:TGOD) Is Doing to Be the Market Leader in Organic Cannabis

Find out how Green Organic Dutchman Holdings Ltd (TSX:TGOD) is creating a niche for itself as the markets leading purveyor of organic cannabis products.

edit Businessman using calculator next to laptop

Image source: Getty Images.

Green Organic Dutchman Holdings Ltd (TSX:TGOD) has a unique vision within the market for Canadian cannabis stocks – and that vision is a clear one.

TGOD seeks to become the undisputed market leader for premium organic cannabis products.

Unlike so many other licensed cannabis producers who seem intent on winning the “race to the bottom” as the industry’s lowest cost producer, Green Organic Dutchman’s approach is different.

Rather than being “all about the money” the company feels strongly that by delivering a distinctly superior product, not only will it be able to carve out a niche for itself within what already becoming a crowded marketplace among suppliers and consumers, but it should in theory be able to charge a premium for its product, in turn driving higher margins for its shareholders.

In its most recent investor presentation, TGOD suggest that it expects to achieve a run-rate of production capacity upwards of 200,000 kg annually by Q4 of 2020.

While securing distribution and filling product orders remains a different question altogether, the company already has supply agreements in place with the Ontario Cannabis Retail Corp (OCS) and Velvet Management, one of the country’s largest wine distributors.

Green Organic is hoping that it can capitalize off the recent popularity of health conscious ventures like Whole Foods, which was recently acquired by Amazon.com, Inc. in August of 2017 for more than $13 billion.

But this isn’t just “pie in the sky” type of thinking, either.

Research put forward by the company in its investor presentation suggests that an organic cannabis option would be preferred by 61% of surveyed medical patients and 50% of recreational users. Meanwhile additional research that suggests some of the chemicals and pesticides used in cannabis concentrates run the risk of producing adverse health effects for the drug’s users.

From a financial point of view, there could be certain benefits to the company’s planned business model.

By employing the use of what it calls “hybrid” facilities, the company hopes that it can keep a lid on operating costs while also lowering the requirement for capital investments compared to conventional indoor grow facilities thanks to advanced technologies designed to take advantage of natural lighting and enhanced humidity, environmental and temperature controls.

Looking ahead to the future, Organic Dutchman has already entered into a strategic joint venture dedicated toward the Latin American market, estimated at US$9.8 billion annually and has also created a partnership with multi-billion dollar food processor Symrise that will see two create a U.S.-based beverage innovation company.

Foolish bottom line

Currently trading at a market capitalization of $875 million, the Green Dutchman is valued at considerably less than larger rivals like Canopy Growth Corp, Aurora Cannabis Inc and even Hexo Corp.

Yet prospective investors in the company’s stock shouldn’t exactly be expecting those fortunes to be changing anytime soon.

Make no mistake, this is an interesting play for cannabis investors seeking something a little different and off the beaten path, but until proven otherwise, the market for organic cannabis products – and TGOD stock – shouldn’t be treated any differently than a niche segment within the broader cannabis markets.

Making the world smarter, happier, and richer.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Jason Phillips has no position in any of the stocks mentioned. David Gardner owns shares of Amazon. The Motley Fool owns shares of Amazon.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Corp: Will it Ever Be a Buy?

Canopy Growth Corp (TSX:WEED) keeps going lower. Will it ever find a bottom?

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks a Good Buy in November 2023?

Cannabis stocks have slumped a long way down in the last few years, so is November the time to get…

Read more »

A cannabis plant grows.
Cannabis Stocks

2 Top Cannabis Stocks to Buy on the TSX Today

Two cannabis stocks are the top picks as the market moves toward consolidation and stability.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

2 Great Cannabis Stocks for New Investors

Quality cannabis companies such as Green Thumb can help long-term investors deliver outsized gains in the upcoming decade.

Read more »

A cannabis plant grows.
Cannabis Stocks

Will Canopy Growth Stock Pass $1 in November 2023?

Canopy Growth (TSX:WEED) stock needs to make some major changes if it hopes to get buyers back on board, and…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Canopy Growth Stock a Buy, Sell, or Hold Right Now?

Shares of Canopy Growth are trading 99% below all-time highs. Here's why WEED stock remains a high risk bet, despite…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

What’s Happening With Cannabis Stocks in November 2023?

Cannabis stocks have come a long way in the last five years -- they've dropped a long way. What can…

Read more »

Caution, careful
Cannabis Stocks

Buyer Beware: Canopy Growth Stock Is at Risk of a Bigger Drop

Canopy Growth Corp (TSX:WEED) stock has given investors a rough ride. Here's why it could get worse.

Read more »